Home/Filings/4/0000875320-25-000005
4//SEC Filing

ALTSHULER DAVID 4

Accession 0000875320-25-000005

CIK 0000875320other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:07 PM ET

Size

6.7 KB

Accession

0000875320-25-000005

Insider Transaction Report

Form 4
Period: 2025-02-04
Transactions
  • Award

    Common Stock

    2025-02-04+12,31438,127 total
  • Award

    Common Stock

    2025-02-04+7,11445,241 total
Footnotes (2)
  • [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025.
  • [F2]Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001550395

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:07 PM ET
Size
6.7 KB